REVIEW
Accepted on 30 Oct 2025
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Research Topics
- Cardiometabolic Crosstalk: Mechanisms, Modulators, and Therapeutics in Diabetes-Induced Cardiovascular Disease
Cardiometabolic Crosstalk: Mechanisms, Modulators, and Therapeutics in Diabetes-Induced Cardiovascular Disease
135
Total downloads
2,690
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 20 Oct 2025
Comparative cardiovascular risks of canagliflozin and selective SGLT2 inhibitors in type 2 diabetes
doi 10.3389/fphar.2025.1686851
- 559 views
REVIEW
Published on 13 Oct 2025
Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk
doi 10.3389/fphar.2025.1683159
- 1,383 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.